2m 2m 2m 2m 2m 2m 2m
Agios Pharm (AGIO)
NASDAQ
$35.60+$0.010 (+0.03%)
Price as of Jun 23, 2026 4:10 PM EDT- $2.1BMarket Cap
- 6.49%1-Year Change
- BiotechnologyIndustry
Agios Pharm (AGIO)
$35.60+$0.010 (+0.03%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 54.0M +48.03% | 36.5M +36.07% | 26.8M +88.36% | 14.2M N/A | |
Cost of Revenue | 6.3M +52.34% | 4.2M +44.57% | 2.9M +69.07% | 1.7M N/A | |
Gross Profit | 47.7M +47.47% | 32.3M +35.05% | 23.9M +90.99% | 12.5M N/A | |
Sales and Marketing Expense | 180.3M +14.99% | 156.8M +30.76% | 119.9M -1.45% | 121.7M +0.19% | |
Research and Development Expense | -339.5M +12.70% | -301.3M +1.95% | -295.5M +5.58% | -279.9M +8.93% | |
Depreciation and Amortization Expense | 5.2M -8.42% | 5.7M -14.65% | 6.6M -22.66% | 8.6M -7.32% | |
Total Operating Expenses | 526.2M +13.83% | 462.2M +10.50% | 418.3M +3.73% | 403.3M +6.57% | |
Operating Profit | -472.1M +10.90% | -425.7M +8.75% | -391.5M +0.63% | -389.0M +2.81% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | 12.8M +1,430.26% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 -100.00% | 12.8M +1,430.26% | |
Total Nonoperating Income and Expense | 2.0M -69.85% | 6.5M +7.13% | 6.1M -10.28% | 6.7M -53.24% | |
Income before Taxes | -413.8M -157.63% | 718.0M +303.92% | -352.1M +51.89% | -231.8M -34.98% | |
Income Taxes | -1.0M -102.30% | 44.2M N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -412.8M -161.27% | 673.7M +291.35% | -352.1M +51.89% | -231.8M -114.44% | |
Net Income from Continuing Operations Applicable to Common | -413.8M -157.63% | 718.0M +303.92% | -352.1M +51.89% | -231.8M -34.98% | |
Basic EPS and Net Income | -7.12 -160.03% | 11.86 +287.36% | -6.33 +49.65% | -4.23 -115.93% | |
Diluted EPS and Net Income | -7.12 -161.17% | 11.64 +283.89% | -6.33 +49.65% | -4.23 -115.93% | |
Basic Weighted Average Shares | 58.0M +2.05% | 56.8M +2.08% | 55.7M +1.57% | 54.8M -9.36% | |
Diluted Weighted Average Shares | 58.0M +0.14% | 57.9M +4.02% | 55.7M +1.57% | 54.8M -9.36% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 89.1M +16.90% | 76.2M -13.56% | 88.2M -36.66% | 139.3M -31.44% | |
Short-Term Investments | 765.3M -6.38% | 817.5M +18.69% | 688.7M +6.97% | 643.9M -21.18% | |
Cash and Cash Equivalents and Short-Term Investments | 854.4M -4.40% | 893.7M +15.03% | 776.9M -0.79% | 783.1M -23.22% | |
Total Current Assets | 942.1M -2.44% | 965.6M +15.80% | 833.8M +0.13% | 832.8M -21.75% | |
Accumulated Depreciation | 60.1M +6.40% | 56.5M +8.17% | 52.2M +4.31% | 50.1M +11.33% | |
Property and Plant and Equipment and Net | 10.8M -7.71% | 11.7M -24.10% | 15.4M -33.08% | 23.0M -20.52% | |
Total Long-Term Assets | 3.9M -16.79% | 4.7M +16.44% | 4.1M +2.55% | 4.0M +36.41% | |
Total Assets | 1.3B -22.00% | 1.7B +77.48% | 937.1M -24.35% | 1.2B -13.84% | |
Income Taxes Payable | 0 -100.00% | 871,000 N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 82.2M +1.29% | 81.2M +19.43% | 68.0M +8.50% | 62.6M +4.69% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 90,000 -89.77% | 880,000 -23.88% | 1.2M -64.75% | 3.3M -96.17% | |
Total Liabilities | 104.1M -14.83% | 122.2M -3.06% | 126.1M -8.56% | 137.9M -5.39% | |
Retained Earnings | -561.7M +277.18% | -148.9M -81.90% | -822.6M +74.82% | -470.6M +97.09% | |
Total Stockholders Equity | 1.2B -22.57% | 1.5B +90.00% | 811.0M -26.33% | 1.1B -14.80% | |
Total Shares Outstanding | 58.4M +2.26% | 57.2M +2.16% | 55.9M +1.64% | 55.0M +1.30% | |
Cash Flow | |||||
Cash from Operating Activities | -373.0M -4.33% | -389.8M +31.68% | -296.1M -4.34% | -309.5M -24.02% | |
Capital Expenditures | 4.3M +156.14% | 1.7M +68.67% | 999,000 -79.53% | 4.9M -14.98% | |
Cash from Investing Activities | 377.2M +3.78% | 363.4M +51.70% | 239.6M -1.52% | 243.3M -80.52% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 8.7M -39.93% | 14.4M +165.82% | 5.4M +131.19% | 2.4M +100.31% | |
Financials Ratio | |||||
Gross Margin | 88.26% -0.38% | 88.59% -0.75% | 89.26% +1.39% | 88.03% N/A | |
Operating Margin | -873.87% -25.08% | -1,166.47% -20.08% | -1,459.52% -46.58% | -2,732.07% N/A | |
Return on Assets | -27.89% -153.82% | 51.82% +260.11% | -32.36% +86.84% | -17.32% -112.36% | |
Return on Equity | -30.20% -152.71% | 57.29% +255.54% | -36.83% +90.10% | -19.37% -110.21% | |
Revenue Growth | 48.03% +33.16% | 36.07% -59.18% | 88.36% N/A | N/A N/A | |
Current Ratio | 11.46 -3.68% | 11.90 -3.03% | 12.27 -7.72% | 13.30 -25.25% | |
Cash Ratio | 1.08 +15.40% | 0.94 -27.62% | 1.30 -41.63% | 2.22 -34.51% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow